Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amedisys Inc - Common Stock (NQ: AMED )

92.57 -0.02 (-0.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Amedisys Inc - Common Stock

Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers 
From Amedisys, Inc.
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
Amedisys Inc. (NASDAQ: AMED) Near the Top of Equities by Percentage Gain on 6/5
Via Investor Brand Network
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Amedisys Announces Receipt of Unsolicited Proposal From Optum
From Amedisys, Inc.
Via GlobeNewswire
AMEDISYS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. - AMED
From Kahn Swick & Foti, LLC
Via Business Wire
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Amedisys Board of Directors Authorizes $100 Million Stock Repurchase Program
From Amedisys, Inc.
Via GlobeNewswire
Amedisys Completes Home Health Joint Venture with the University of Arkansas for Medical Sciences
From Amedisys, Inc.
Via GlobeNewswire
Amedisys is Named One of the Most Responsible Companies of 2023 by Statista and Newsweek
From Amedisys, Inc.
Via GlobeNewswire
Amedisys Names Scott Ginn Acting Chief Operating Officer
From Amedisys, Inc.
Via GlobeNewswire
Amedisys Statement on CY 2023 Home Health Final Rule
From Amedisys, Inc.
Via GlobeNewswire
University of Arkansas for Medical Sciences (UAMS) Announces a Partnership with Amedisys and Contessa, Creating a Comprehensive Care at Home Suite of Services
From Amedisys, Inc.
Via GlobeNewswire
Global Home Medical Equipment Market Size Is Estimated To Reach $56 Billion By 2027
Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – Over the last few years, and with the ‘help’ of the pandemic, home health care medical equipment industry has surged. Home... 
Via FinancialNewsMedia
Hospital Care at Home: Henry Ford Health System and Contessa Partner to Create New Choice for Patients
From Contessa
Via Business Wire
U.S. Home Medical Equipment Market Expected to Reach $20 Billion By 2027
Via FinancialNewsMedia
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.